Vor Biopharma Competitors and Similar CompaniesClear all
Vor Biopharma's competitors and similar companies include Geneos Therapeutics, Fusion Pharmaceuticals, Shoreline Biosciences and Elicio Therapeutics.
 Vor Biopharma Vor Biopharma is a biopharmaceutical company developing novel therapies for treating cancer. |  Geneos Therapeutics Geneos Therapeutics is a biotherapeutics company that develops DNA-based personalized therapeutic cancer vaccines. |  Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer. |  Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms. |  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | |
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 2014 | Founding Date 2020 | Founding Date 2011 |
Type | Type Public | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Plymouth Meeting, US HQ | Locations Hamilton, CA HQ Boston, US | Locations San Diego, US HQ San Diego, US | Locations Cambridge, US HQ |
Employees | Employees 1595% decrease | Employees 128% decrease | Employees 101 | Employees 4716% decrease | Employees 22 |
Valuation ($) | Valuation ($) 50.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 47.5 m |
Financial | |||||
Net income | Net income ($696m) (FY, 2025) | Net income N/A | Net income ($94.9m) (FY, 2023) | Net income N/A | Net income ($39.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 12m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 43m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 152m | Total funding raised $ 22.5m | Total funding raised $ 170.9m | Total funding raised $ 46m | Total funding raised $ 150.3m |
For sources of this data, please see the company profile
View Company Profiles
Geneos Therapeutics
HQ
Plymouth Meeting, US
Employees
12↓ 8% decrease
Geneos Therapeutics is a biotherapeutics company that develops DNA-based personalized therapeutic cancer vaccines.
View companyFusion Pharmaceuticals
HQ
Hamilton, CA
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.
View companyShoreline Biosciences
HQ
San Diego, US
Employees
47↓ 16% decrease
Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company